C. elegans Anchor Cell Fate Determination

In the developing vulva of the C. elegans hermaphrodite, two equivalent cells, Z1.ppp and Z4.aaa, compete to become the anchor cell. This process is a classic example of lateral inhibition, a signaling mechanism where a cell that adopts a particular fate inhibits its neighbors from doing the same. The interaction between these two cells is mediated primarily by the Notch signaling pathway components.

Role of LAG-2 and LIN-12 in Cell Fate

The Notch signaling pathway involves a ligand (like LAG-2) and a receptor (like LIN-12, the C. elegans Notch homolog). In this context:

• LAG-2 acts as the ligand. It is a transmembrane protein displayed on the surface of the signaling cell.
• LIN-12 acts as the receptor. It is a transmembrane protein on the surface of the receiving cell.

The cell with initially higher levels of LAG-2 will signal more strongly to its neighbor via LIN-12. This strong LIN-12 activation in the receiving cell inhibits its ability to become the anchor cell. Conversely, the cell that is signaling strongly with LAG-2 (and receiving less inhibitory signal via its own LIN-12) is then biased to become the anchor cell. The cell receiving the strong LIN-12 signal takes on the ventral uterine precursor fate.

Analyzing the Statements

Let's look at the given statements based on this understanding:

• A. The cell secreting LAG-2 becomes the anchor cell. This statement aligns with the model of lateral inhibition via Notch signaling. The cell that signals strongly with LAG-2 is the one that becomes the anchor cell, inhibiting its neighbor. This statement is consistent with the biological mechanism.
• B. The cell secreting LIN-12 remains as the precursor of the uterine tissue. LIN-12 is the receptor, not typically "secreted". However, the statement likely refers to the cell that *displays* LIN-12 on its surface and *receives* the signal. This cell, upon strong activation by LAG-2 from its neighbor, is inhibited from becoming the anchor cell and takes the uterine precursor fate. Interpreting "secreting LIN-12" as "involved in LIN-12 signaling as the receiving cell", this statement is consistent with the cell receiving the strong inhibitory signal becoming the uterine precursor.
• C. The LIN-12 secreting cell takes the fate of anchor cell while the LAG-2 secreting cell takes the fate of uterine precursor cell. This statement is the reverse of what is observed and described by the lateral inhibition mechanism. The cell secreting LAG-2 becomes the anchor cell, and the cell receiving the LIN-12 signal becomes the uterine precursor. Therefore, this statement is incorrect.
• D. The Hippo kinase signaling pathway brings lateral inhibition so that one cell is inhibited and the other cell is promoted to become the anchor cell. While the Hippo pathway is involved in regulating organ growth and cell fate in various contexts, the primary mechanism for lateral inhibition between Z1.ppp and Z4.aaa in C. elegans vulva development is the Notch (LAG-2/LIN-12) pathway, not the Hippo pathway. Therefore, this statement is incorrect in this specific context.

Based on the analysis, statements A and B accurately describe the outcome of the interaction between Z1.ppp and Z4.aaa through the Notch signaling pathway.